Hyperhomocysteinemia, Enzyme Polymorphism and Thiobarbituric Acid Reactive System in Children with High Coronary Risk Family History

REFERENCES

• Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, Bazzarre T: Cardiovascular health in childhood. A statement for health professionals from the Committee on Atherosclerosis, Hypertension and Obesity in the Young. Circulation106 :143– 160,2002 .
   PubMed Web of Science ®Google Scholar
• Berenson GS, Srinivasan SR, Bao W, Newman III WP, Tracy RE, Wattigney WA: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med338 :1650– 1656,1998 .
   PubMed Web of Science ®Google Scholar
• Szamosi T, Murber A, Szamosi Jr T, Tory V, Kosztolicz Á, Sztankits K: Atherosclerosis risk factors in children of high risk families. Acta Physiol Hung86 :185– 190,1999 .
   PubMedGoogle Scholar
• Klausen IC, Beisiegel U, Menzel H-J, Rosseneu M, Nicaud V, Faergeman O: Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. Arterioscler Thromb Vasc Biol15 :1001– 1008,1995 .
   PubMedGoogle Scholar
• Islam S, Gutin B, Smith C, Treiber F, Kamboh MI: Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease. Atheroscler Thromb Vasc Biol14 :1609– 1616,1994 .
   PubMedGoogle Scholar
• Szamosi T, Hacsek G, Szamosi A, Popovits I, Venekei I, Javor A: Different cholesterol fractions, LCAT activity and lipid peroxides in the serum of children whose parents had early coronary heart disease. Clin Biochem.21 :97– 99,1988 .
   PubMedGoogle Scholar
• Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med337 :230– 236,1997 .
   PubMed Web of Science ®Google Scholar
• Duell PB, Malinow MR: Homocysteine: an important risk factor for atherosclerotic vascular disease. Cur Opin Lipidol8 :28– 34,1997 .
   PubMed Web of Science ®Google Scholar
• Malinow MR: Plasma homocysteine and arterial occlusive diseases: A Mini-review. Clin Chem40 :173– 176,1994 .
   Google Scholar
• Kilmer S, McCully MD: Homocysteine, folate, vitamin B6, and cardiovascular disease. JAMA279 :392– 393,1998 .
   PubMedGoogle Scholar
• Siri PW, Verhoef P, KSok FJ: Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr17 :435– 441,1998 .
   PubMed Web of Science ®Google Scholar
• Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR: The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol17 :1157– 1162,1997 .
   PubMed Web of Science ®Google Scholar
• Anderson JL, King GJ, Thomson MJ, Todd M, Bair TL, Muhlestein RT, Carlquist JF: A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol30 :1206– 1211,1997 .
   PubMedGoogle Scholar
• Chao CL, Tsai HH, Lee CM, Hsu SM, Kao JT, Chien KL, Sung FC, Lee YT: The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis147 :379– 386,1999 .
   PubMed Web of Science ®Google Scholar
• Margaglione M, Colaizzo D, Cappucci G, del Popolo A, Vecchione G, Grandone E, Di Minno G: Genetic polymorphism of 5, 10-MTHFR reductase gene in offspring of patients with myocardial infarction. Thromb Haemost82 :19– 23,1999 .
   Google Scholar
• Hirano K, Ogihara I, Miki M, Yasuda H, Kawamura N, Mino M: Homocysteine induces iron-catalyzed lipid peroxidation and susceptibility of low density lipoprotein that is prevented by alpha-tocopherol. Free Rad Res21 :267– 276,1994 .
   PubMed Web of Science ®Google Scholar
• Yagi K: Assay for serum lipid peroxide level and its clinical significance. In Yagi K (ed): “Lipid Peroxides in Biology and Medicine.” New York: Academic Press, pp223– 242,1982 .
   Google Scholar
• Friedewald WT, Levy RT, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem18 :499– 502,1972 .
   PubMed Web of Science ®Google Scholar
• Frantzen F, Faaren AL, Alfheim I, Nordhei AK: Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem44 :311– 316,1998 .
   PubMed Web of Science ®Google Scholar
• Vilaseca MA, Moyano D, Ferrer I, Artuch R: Total homocysteine in pediatric patients. Clin Chem43 :690– 692,1997 .
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van der Heuvel LP, Rozen R: A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet10 :111– 113,1995 .
   PubMed Web of Science ®Google Scholar
• Berg K: Genetics of coronary heart disease. In Steinberg AG, Bearn AG, Motulsky AS (eds): “Progress in Medical Genetics,” vol 5. Philadelphia: Saunders Co,1983 .
   Google Scholar
• Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, De Franceschi M, Belardinelli R, Guazzi MD: Oxidative stress and homocysteine in coronary artery disease. Clin Chem47 :887– 892,2001 .
   PubMed Web of Science ®Google Scholar
• Draper H, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol186 :421– 431,1990 .
   PubMed Web of Science ®Google Scholar
• Haliwell B, Chirico S: Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr57 :715S– 725S,1993 .
   PubMed Web of Science ®Google Scholar
• Berenson GS, McMahan CA, Voors AV, Webber LS, Srinivasan SR, Frank GC, Foster TA, Blonde CV: “Cardiovascular Risk Factors in Children—The Early Natural History of Atherosclerosis and Essential Hypertension.” New York: Oxford University Press,1980 .
   Google Scholar
• Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia an independent risk factor for vascular disease. N Engl J Med324 :1149– 1155,1991 .
   PubMed Web of Science ®Google Scholar